The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Popular anti-obesity medications continue to be effective for weight loss even when availability and access is interrupted, ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes, according to a new study being presented Monday at ENDO 2025, ...

A phenotype-based profiling test can help predict whether a patient might respond better to one antiobesity medicine or ...

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...